Odporúčania EULAR pre manažment reumatoidnej artritídy syntetickými a biologickými ochorenie modifikujúcimi antireumatickými liekmi: Aktualizácia 2013

Translated title of the contribution: EULAR recommendations for the managements of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 Update

J. S. Smolen, R. Landewé, F. C. Breedveld, M. Buch, G. Burmester, M. Dougados, P. Emery, C. Gaujoux-Viala, L. Gossec, J. Nam, S. Ramiro, K. Winthrop, M. De Wit, D. Aletaha, N. Betteridge, J. W.J. Bijlsma, M. Boers, F. Buttgereit, B. Combe, M. CutoloN. Damjanov, J. M.W. Hazes, M. Kouloumas, T. K. Kvien, X. Mariette, K. Pavelka, P. L.C.M. Van Riel, A. Rubbert-Roth, M. Scholte-Voshaar, D. L. Scott, T. Sokka-Isler, J. B. Wong, D. Van Der Heijde

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'EULAR recommendations for the managements of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 Update'. Together they form a unique fingerprint.

Medicine & Life Sciences